Pacira BioSciences Files Proxy Statement
Ticker: PCRX · Form: DEFA14A · Filed: Apr 18, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | DEFA14A |
| Filed Date | Apr 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, corporate-governance
Related Tickers: PCRX
TL;DR
Pacira BioSciences (PCRX) filed its proxy statement, shareholders vote soon.
AI Summary
Pacira BioSciences, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 18, 2025. This filing is soliciting material under Rule 14a-12, indicating it contains information for shareholders regarding a meeting or vote. The company, formerly known as Pacira Pharmaceuticals, Inc., is headquartered in Brisbane, California.
Why It Matters
This filing is important for shareholders as it provides information related to upcoming corporate decisions or votes, allowing them to make informed choices.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not inherently present new risks to the company or its investors.
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- Pacira Pharmaceuticals, Inc. (company) — Former company name
- 2000 Sierra Point Parkway, Suite 900, Brisbane, CA 94005 (company) — Business and mailing address
- 650-242-8052 (company) — Business phone number
FAQ
What is the purpose of this DEFA14A filing?
The DEFA14A filing is a Definitive Proxy Statement filed by Pacira BioSciences, Inc. on April 18, 2025, serving as soliciting material under Rule 14a-12.
What was Pacira BioSciences, Inc. formerly known as?
Pacira BioSciences, Inc. was formerly known as Pacira Pharmaceuticals, Inc., with a name change date of October 29, 2010.
Where is Pacira BioSciences, Inc. located?
The company's business and mailing address is 2000 Sierra Point Parkway, Suite 900, Brisbane, CA 94005.
What is the SIC code for Pacira BioSciences, Inc.?
The Standard Industrial Classification (SIC) code for Pacira BioSciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Is there a fee required for this filing?
According to the filing, no fee is required for this DEFA14A filing.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 18, 2025 regarding Pacira BioSciences, Inc. (PCRX).